国邦医药(605507.SH)：公司股东拟协议转让股份引入战略投资者

Core Viewpoint - Guobang Pharmaceutical (605507.SH) has signed a share transfer agreement with Zhejiang State-owned Capital Operation Co., Ltd. to transfer 38,306,303 shares, representing 6.85% of the total share capital, to support the company's strategic development in the pharmaceutical industry [1][2] Group 1 - The share transfer involves major shareholders, including Weifang Shiqihui Equity Investment Partnership, Weifang Hongdehui Equity Investment Partnership, and Shaoxing Shiqingde Enterprise Management Consulting Partnership, who will collectively hold 4.91% of the company's shares after the transfer [1] - The state-owned operation company aims to support the comprehensive development of the company in the pharmaceutical sector, focusing on areas such as industrial chain collaboration, new business cultivation, and capital operations [2] - Future cooperation will involve personnel exchanges and collaborative efforts in investment project evaluation, new technology validation, application scenarios, and think tank consulting, with specific details to be negotiated and formalized in subsequent agreements [2]